Target & Activity
| Target | Activity | Value |
|---|---|---|
| PPARα |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| BHK-21 | EC50 | > 100 μM | Antiviral activity against YFV infected in BHK-21 cells assessed as inhibition of virus-induced cytopathogenicity after 3 to 4 days by MTT assay | [PMID: 26443549] |
| CV-1 | EC50 | 147.8 μM | Agonist activity at human PPARgamma in CV1 cells by GAL4 transactivation assay after 24 hrs | [PMID: 17507225] |
| CV-1 | EC50 | 147.8 μM | Agonist activity at human PPARgamma ligand binding domain expressed in african green monkey CV1 cells co-transfected with fused Gal4-DBD by transactivation assay | [PMID: 18826205] |
| CV-1 | EC50 | 193.3 μM | Agonist activity at human PPARalpha in CV1 cells by GAL4 transactivation assay after 24 hrs | [PMID: 17507225] |
| CV-1 | EC50 | 193.3 μM | Agonist activity at human PPARalpha ligand binding domain expressed in african green monkey CV1 cells co-transfected with fused Gal4-DBD by transactivation assay | [PMID: 18826205] |
| HEK293 | IC50 | 11 μM | Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using estradiol-17beta-glucuronide substrate | [PMID: 22587986] |
| HEK293 | IC50 | 130 μM | Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using estrone-3-sulfate substrate | [PMID: 22587986] |
| HEK293 | IC50 | 38 μM | Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using pitavastatin substrate | [PMID: 22587986] |
| HEK293 | EC50 | 59 μM | Transactivation of human PPARalpha expressed in HEK293 cells incubated for 18 hrs by dual luciferase reporter gene assay | 10.1039/C5MD00151J |
| HEK293 | EC50 | 59 μM | Agonist activity at Gal4-fused PPARalpha expressed in HEK293 cells after 18 hrs by dual luciferase reporter gene assay | [PMID: 21889235] |
| MT4 | CC50 | > 100 μM | Cytotoxicity against human MT4 cells assessed as cell viability after 96 hrs by MTT assay | [PMID: 26443549] |
| Vero 76 | EC50 | > 100 μM | Antiviral activity against human CVB5 infected in african green monkey Vero76 cells assessed as inhibition of virus-induced cytopathogenicity after 3 days by plaque reduction assay | [PMID: 26443549] |
| Vero 76 | CC50 | > 100 μM | Cytotoxicity against african green monkey Vero 76 cells assessed as cell viability after 48 to 96 hrs by crystal violet staining method | [PMID: 26443549] |
| Vero 76 | EC50 | > 100 μM | Antiviral activity against human RSV infected in african green monkey Vero76 cells assessed as inhibition of virus-induced cytopathogenicity after 5 days by plaque reduction assay | [PMID: 26443549] |
| Vero 76 | EC50 | > 100 μM | Antiviral activity against Human poliovirus 1 Sabin infected in african green monkey Vero76 cells assessed as inhibition of virus-induced cytopathogenicity by plaque reduction assay | [PMID: 26443549] |
15 records · Scroll to view more